Main Street Capital Corporation's SEC filings document a principal investment firm's financial results, portfolio activity, dividends and capital structure. Current reports furnish operating results and preliminary estimates, announce monthly and supplemental dividend actions, and report private loan portfolio activity tied to its lower middle market and private loan investment strategies.
Other filings cover material debt agreements, including unsecured senior notes, and proxy governance matters such as director elections, auditor ratification, executive compensation and shareholder voting results. The filings also identify the company's Maryland incorporation, common stock voting matters and registered investment adviser activities conducted through MSC Adviser I, LLC.
Main Street Capital Corp Form 144 filing discloses a proposed sale of securities by Executive Officer Jesse E. Morris. The planned transaction involves 35,000 shares of common stock with an aggregate market value of $2,076,200, to be executed through Raymond James & Associates on the NYSE around June 27, 2025.
The shares were acquired through restricted stock vesting between April 1, 2023, and April 1, 2024, as part of compensation. Key details include:
- Total outstanding shares: 89,029,361
- Sale represents approximately 0.04% of outstanding shares
- No other securities were sold by the insider in the past 3 months
- Trading execution planned through Raymond James & Associates
The filing includes standard attestation that the seller has no knowledge of undisclosed material adverse information regarding the company's operations. The notice was signed by Jason B. Beauvais as Attorney-in-Fact.
Main Street Capital Corp Officer Jason B. Beauvais filed a Form 144 notice for the proposed sale of 13,664 shares of common stock with an aggregate market value of $810,548.48. The sale is planned to execute on the NYSE through Raymond James & Associates on June 27, 2025.
The securities were originally acquired through restricted stock vesting between April 1, 2019, and April 1, 2021, as part of compensation. The total shares outstanding are 89,029,361.
Key points:
- No other securities sales reported by the officer in the past 3 months
- Officer confirms no knowledge of undisclosed material adverse information
- Transaction represents approximately 0.015% of total shares outstanding
- Average price per share: ~$59.32